4//SEC Filing
Mann Paul Elliot 4
Accession 0001493152-21-000247
CIK 0000318306other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:07 PM ET
Size
7.6 KB
Accession
0001493152-21-000247
Insider Transaction Report
Form 4
Mann Paul Elliot
Director
Transactions
- Sale
Common Stock
2021-01-04$1.54/sh−30,488$46,891→ 132,664 total - Disposition to Issuer
Common Stock
2020-12-31−609,755→ 163,152 total
Footnotes (3)
- [F1]Represents unvested shares of restricted common stock granted to the reporting person on October 8, 2020 in connection with the formation of a special committee of the Issuer's board of directors as reported on Form 8-K on October 6, 2020. These shares were scheduled to vest in monthly installments only while the special committee was operational and the reporting person was providing service to the special committee; the special committee was dissolved on December 31, 2020. The reporting person continues to serve on the Issuer's board of directors.
- [F2]The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 19, 2020.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.50 to $1.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
Documents
Issuer
ABEONA THERAPEUTICS INC.
CIK 0000318306
Entity typeother
Related Parties
1- filerCIK 0001744816
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 7:07 PM ET
- Size
- 7.6 KB